The Sb14-3-3ζ recombinant protein protects against Schistosoma bovis in BALB/c mice

Vaccine

Volumn 25, Issue 23, 2007, Pages 4533-4539

  Uribe, N ^a   Siles Lucas, M ^a   Lopez Aban J ^a   Esteban, A ^a   Suarez, L ^a   Martinez Fernandez A ^b   del Olmo, E ^a   Muro, A ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

14 3 3 Vaccination; Immunomodulators; Schistosoma bovis

Indexed keywords

IMMUNOMODULATING AGENT; PROTEIN 14 3 3; PROTEIN SB14 3 3ZETA; RECOMBINANT PROTEIN; SCHISTOSOMA VACCINE; UNCLASSIFIED DRUG; CYTOKINE; HELMINTH ANTIBODY; IMMUNOLOGICAL ADJUVANT; RECOMBINANT VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROPHYLAXIS; SCHISTOSOMA BOVIS; SCHISTOSOMIASIS; TH1 CELL; VACCINATION; ANIMAL; BIOSYNTHESIS; BLOOD; CPG ISLAND; IMMUNIZATION; IMMUNOLOGY; SCHISTOSOMA;

14-3-3 PROTEINS; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, HELMINTH; CPG ISLANDS; CYTOKINES; FEMALE; IMMUNIZATION; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; SCHISTOSOMA; VACCINES, SYNTHETIC;

EID: 34248380936     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.04.024     Document Type: Article

References (27)

1. Gryseels B., Mbaye A., De Vlas S.J., Stelma F.F., Guisse F., Van Lieshout L., et al. Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence. Trop Med Int Health 6 11 (2001) 864-873
2. Geerts S., and Gryseels B. Drug resistance in human helminths: current situation and lessons from livestock. Clin Microbiol Rev 13 2 (2000) 207-222
3. Bergquist N.R. Schistosomiasis vaccine development: approaches and prospect. Mem Inst Oswaldo Cruz 90 (1995) 221-227
4. Berguist N.R., and Colley D.G. Schistosomiasis vaccines: research to development. Parasitol Today 14 (1998) 99-104
5. Bashir M., Bickle Q., Bushara H., Cook L., Shi F., He D., et al. Evaluation of defined antigen vaccines against Schistosoma bovis and S. japonicum in bovines. Trop Geogr Med 46 4 Spec No (1994) 255-258
6. Yaffe M.B. How do 14-3-3 protein work? Gatekeeper phosphorylation and the molecular anvil hypotesis. FEBS Lett 513 (2002) 53-57
7. MacGonigle S., Beall M.J., Feeney E.L., and Pearce E.J. Conserved role for 14-3-3e downsteam of type I TGFB receptors. FEBS Lett 490 (2001) 65-69
8. MacGonigle S., Feeney E.L., Beall M.J., and Pearce E.J. SIP, a novel SH3 domain-containing protein, interacts with Schistosoma mansoni receptor kinase 1. Mol Biochem Parasitol 114 (2001) 119-123
9. Schechtman D., Tarrab-Hazdai R., and Arnon R. The 14-3-3 protein as a vaccine candidate against schistosomosis. Parasite Immunol 23 (2001) 213-217
10. Zhang Y., Taylor M.G., McCrossan M.V., and Bickle Q.D. Molecular cloning and characterization of a novel Schistosoma japonicum "irradiated vaccine-specific" antigen, Sj14-3-3. Mol Biochem Parasitol 103 1 (1999) 25-34
11. Siles-Lucas M., and Gottstein B. The 14-3-3 protein: a key molecule in parasites as in other organisms. Trends Parasitol 19 (2003) 575-581
12. Uribe N, Muro A, López J, Vieira C, Del Olmo E, Suárez L, et al. Genetic and immunological characterization of the 14-3-3ζ molecule from Schistosoma bovis. J Parasitol, in press.
13. Pardo J., Carranza C., Turrientes M.C., Perez Arellano J.L., Lopez Velez R., Ramajo V., et al. Utility of Schistosoma bovis adult worm antigens for diagnosis of human schistosomiasis by enzyme-linked immunosorbent assay and electroimmunotransfer blot techniques. Clin Diagn Lab Immunol 11 6 (2004) 1165-1170
14. Siles-Lucas M., Felleisen R.S., Hemphill A., Wilson W., and Gottstein B. Stage-specific expression of the 14-3-3 gene in Echinococcus multilocularis. Mol Biochem Parasitol 91 2 (1998) 281-293
15. Siles-Lucas M., Nunes C.P., and Zaha A. Comparative analysis of the 14-3-3 gene and its expression in Echinococcus granulosus and Echinococcus multilocularis metacestodes. Parasitology 122 Pt 3 (2001) 281-287
16. Kumar S., Jones T.R., Oakley M.S., Zheng H., Kuppusamy S.P., Taye A., et al. CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine. Infect Immun 72 (2004) 949-957
17. Martinez-Fernandez A.R., Nogal-Ruiz J.J., Lopez-Aban J., Ramajo V., Oleaga A., Manga-Gonzalez Y., et al. Vaccination of mice and sheep with Fh12 FABP from Fasciola hepatica using the new adjuvant/immunomodulator system ADAD. Vet Parasitol 126 3 (2004) 287-298
18. Olmo E.D., Plaza A., Muro A., Martinez-Fernandez A.R., Nogal-Ruiz J.J., Lopez-Perez J.L., et al. Synthesis and evaluation of some lipidic aminoalcohols and diamines as immunomodulators. Bioorg Med Chem Lett 16 23 (2006) 6091-6095
19. Dea-Ayuela M., Rodero M., Rodriguez-Bueno R., Bolas-Fernandez F., and Martinez-Fernandez A.R. Modulation by Anapsos (Polypodium leucotomos extract) of the antibody responses against the nematode parasite Trichinella spiralis. Phytother Res 13 (1999) 566-570
20. Nogal-Ruiz J.J., Gomez-Barrio A., Escario J.A., and Martinez-Fernandez A.R. Effect of Anapsos in a murine model of experimental trichomoniasis. Parasite 10 (2003) 303-308
21. López-Abán J., Oleaga A., Ramajo V., Casanueva P., Perez J.L., Hillyer G.V., et al. Vaccination of mice against Schistosoma bovis with a recombinant fatty acid binding protein from Fasciola hepatica. Vet Parasitol 91 (2000) 33-42
22. Bosze S., Caccamo N., Majer Z., Mezo G., Dieli F., and Hudecz F. In vitro T-cell immunogenicity of oligopeptides derived from the region 92-110 of the 16-kDa protein of Mycobacterium tuberculosis. Biopolymers 76 (2004) 467-476
23. Agnew A.M., Murare H.M., and Doenhoff M.J. Specific cross-protection between Schistosoma bovis and S. haematobium induced by highly irradiated infections in mice. Parasite Immunol 11 4 (1989) 341-349
24. Boulanger D., Trottein F., Mauny F., Bremond P., Couret D., Pierce R.J., et al. Vaccination of goats against the trematode Schistosoma bovis with a recombinant homologus schistosome-derived glutation S-transferase. Parasite Immunol 16 (1994) 399-406
25. Majid A.A., Bushara H.O., Saad A.M., Hussein M.F., Taylor M.G., Dargie J.D., et al. Observations on cattle schistosomiasis in the Sudan, a study in comparative medicine. III. Field testing of an irradiated Schistosoma bovis vaccine. Am J Trop Med Hygiene 29 3 (1980) 452-455
26. Attallah A.M., Attia H., Ismail H., Yones E., El-Nashar E.M., Abd El-Kader K., et al. Vaccination against Schistosoma mansoni infection using 74 kDa Schistosoma protein antigen. Vaccine 17 22 (1999) 2786-2791
27. Fonseca C.T., Brito C.F., Alves J.B., and Oliveira S.C. IL-12 enhances protective immunity in mice engendered by immunization with recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein through an IFN-gamma and TNF-alpha dependent pathway. Vaccine 22 3/4 (2004) 503-510